Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris (PAUSE)
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
To be updated
应用场景：
创建时间：
2024-07-29
相关数据集
Supplementary Material for: Tofacitinib in Pediatric Psoriasis: An Open-Label Trial to Study Its Safety and Efficacy in Children
Introduction: Psoriasis is a chronic, multifactorial, inflammatory disorder, with an estimated prevalence of 0.71% in children. The commonly used therapeutic agents target the underlying inflammation.
NIAID Data Ecosystem100
Supplementary Material for: Treatment of plaque psoriasis with guselkumab reduces systemic inflammatory burden as measured by neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and monocyte/lymphocyte ratio: A post hoc analysis of three randomised clinical trials
Background Psoriasis is associated with an increased risk of cardiovascular disease (CVD). Previous studies have found that treatment with tumour necrosis factor or interleukin (IL)-17 inhibitors lead
DataCite Commons2025-06-01 更新80
Supplementary Material for: Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study
Background: Topical agents are still the mainstay for the treatment of mild-to-moderate plaque psoriasis, in which fixed combinations play an important role. Tazarotene/betamethasone dip
DataCite Commons2025-06-01 更新50
Head-to-head comparison of risankizumab and ixekizumab in GenPs
Methodology; Figure 1c; Table 1
NIAID Data Ecosystem90
A pharmacokinetic study on the intralesional administration of methotrexate in patients with nail psoriasis.
This dataset contains supplementary methods and results for the article "A pharmacokinetic study on the intralesional administration of methotrexate in patients with nail psoriasis.", submitted to Jou
Mendeley Data50
